Sleep disturbance and cholinergic degeneration in Alzheimer's disease [ 2013 - 2016 ]

Also known as: Sleep disturbance and degeneration in Alzheimer's disease

Research Grant

[Cite as]

Researchers: Prof Elizabeth Coulson (Principal investigator) ,  A/Pr Mark Bellingham

Brief description The largest class of drugs given to Alzheimer's disease patients aims to increase the function of cholinergic neurons that degenerate early in the disease. We will test whether disturbed sleep, which has been linked to Alzheimer's disease and cognitive decline are caused by neurodegeneration of these neurons, and whether early treatment can slow disease progression.

Funding Amount $AUD 860,912.62

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]